Jagsonpal Pharmaceuticals Limited

NSEI:JAGSNPHARM Rapporto sulle azioni

Cap. di mercato: ₹10.0b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Jagsonpal Pharmaceuticals Gestione

Gestione criteri di controllo 0/4

Jagsonpal Pharmaceuticals' Il CEO è Manish Gupta, nominato in Jul2022, e ha un mandato di 2.08 anni. la retribuzione annua totale è ₹ 10.59M, composta da 100% di stipendio e 0% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 2.3% delle azioni della società, per un valore di ₹ 227.85M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 1.5 anni e 2.2 anni.

Informazioni chiave

Manish Gupta

Amministratore delegato

₹10.6m

Compenso totale

Percentuale dello stipendio del CEO100.0%
Mandato del CEO2.1yrs
Proprietà del CEO2.3%
Durata media del management1.5yrs
Durata media del Consiglio di amministrazione2.2yrs

Aggiornamenti recenti sulla gestione

Recent updates

There May Be Some Bright Spots In Jagsonpal Pharmaceuticals' (NSE:JAGSNPHARM) Earnings

May 27
There May Be Some Bright Spots In Jagsonpal Pharmaceuticals' (NSE:JAGSNPHARM) Earnings

There's Reason For Concern Over Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) Massive 27% Price Jump

Apr 30
There's Reason For Concern Over Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) Massive 27% Price Jump

A Look At The Fair Value Of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Apr 05
A Look At The Fair Value Of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Investor Optimism Abounds Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) But Growth Is Lacking

Feb 06
Investor Optimism Abounds Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) But Growth Is Lacking

Estimating The Intrinsic Value Of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Jul 29
Estimating The Intrinsic Value Of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

A Look At The Intrinsic Value Of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

May 13
A Look At The Intrinsic Value Of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Does Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM) Deserve A Spot On Your Watchlist?

Jul 05
Does Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM) Deserve A Spot On Your Watchlist?

A Look At The Fair Value Of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Jun 13
A Look At The Fair Value Of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) 0.6% Dividend Yield Looks Pretty Interesting

Apr 19
Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) 0.6% Dividend Yield Looks Pretty Interesting

Should You Be Adding Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM) To Your Watchlist Today?

Mar 21
Should You Be Adding Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM) To Your Watchlist Today?

Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) Stock Is Going Strong: Have Financials A Role To Play?

Feb 08
Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) Stock Is Going Strong: Have Financials A Role To Play?

The Attractive Combination That Could Earn Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) A Place In Your Dividend Portfolio

Jan 08
The Attractive Combination That Could Earn Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) A Place In Your Dividend Portfolio

Here's Why I Think Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM) Is An Interesting Stock

Dec 21
Here's Why I Think Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM) Is An Interesting Stock

Are Jagsonpal Pharmaceuticals's (NSE:JAGSNPHARM) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Nov 30
Are Jagsonpal Pharmaceuticals's (NSE:JAGSNPHARM) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Manish Gupta rispetto agli utili di Jagsonpal Pharmaceuticals?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

₹203m

Mar 31 2024n/an/a

₹225m

Dec 31 2023n/an/a

₹245m

Sep 30 2023n/an/a

₹283m

Jun 30 2023n/an/a

₹313m

Mar 31 2023₹11m₹11m

₹267m

Compensazione vs Mercato: La retribuzione totale di Manish ($USD 126.28K ) è superiore alla media delle aziende di dimensioni simili nel mercato Indian ($USD 37.56K ).

Compensazione vs guadagni: Dati insufficienti per confrontare la retribuzione di Manish con le performance aziendali.

AMMINISTRATORE DELEGATO

Manish Gupta (57 yo)

2.1yrs

Mandato

₹10,590,000

Compensazione

Mr. Manish Gupta serves as Operating Partner at Convergent Finance LLP since joining the firm in July 2022. At Convergent, he helps identify and diligence investment opportunities. He is the former CEO and...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Manish Gupta
MD & Director2.1yrs₹10.59m2.3%
₹ 229.2m
Abhishek Joshi
Company Secretary & Compliance Officer1.5yrs₹100.00kNessun dato
Ashish Lakhotia
Chief Financial Officerless than a yearNessun datoNessun dato
Bharat Chugh
Assistant General Manager of Human Resourcesno dataNessun datoNessun dato

1.5yrs

Durata media

Gestione esperta: Il team dirigenziale di JAGSNPHARM non è considerato esperto (durata media 1.5 anni), il che suggerisce un nuovo team.

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Manish Gupta
MD & Director2.1yrs₹10.59m2.3%
₹ 229.2m
Harsha Raghavan
Non-Executive Chairman2.2yrsNessun datoNessun dato
Rajpal P. Kochhar
Chairman Emeritusno data₹6.81m4.58%
₹ 457.3m
Prithipal Kochhar
Non-Executive Director2.2yrsNessun dato0.36%
₹ 36.0m
Pallavi Gupta
Independent Director2.2yrs₹1.00mNessun dato
Debasis Nandy
Independent Director2.2yrs₹1.08mNessun dato
Radhika Dudhat
Independent Director2.2yrs₹950.00kNessun dato

2.2yrs

Durata media

54yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di JAGSNPHARM non è considerato esperto (durata media del mandato 2.2 anni), il che suggerisce un nuovo consiglio.